Use of taurine in prevention and/or treatment of diseases induced by viruses of genus coronavirus and/or genus rotavirus
The present invention provides use of taurine in prevention and/or treatment of diseases induced by viruses of genus coronavirus and/or genus rotavirus, for example, porcine epidemic diarrhea, porcine transmissible gastroenteritis, rotavirus diarrhea and the like.
1. A method for treating porcine viral diarrhea by orally administering a patient a drug consisting of taurine as an active ingredient, wherein the taurine is administered at 10-20000 mg per kilogram of body weight.
2. The method according to claim 1 , wherein the porcine viral diarrhea is a disease induced by viruses of genus coronavirus or genus rotavirus.
3. The method according to claim 2 , wherein the disease induced by viruses of the genus coronavirus is porcine epidemic diarrhea or porcine transmissible gastroenteritis.
4. A drug for oral treatment of porcine viral diarrhea, consisting of taurine as an active ingredient, wherein the taurine is administered at 10-20000 mg per kilogram of body weight.
5. The drug according to claim 4 , wherein the porcine viral diarrhea is a disease induced by viruses of genus coronavirus or genus rotavirus.
6. The drug according to claim 5 , wherein the disease induced by viruses of the genus coronavirus is porcine epidemic diarrhea.